{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:00:50Z","timestamp":1792814450345,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n-Secihti","award":["Posdoctorado CVU: 620020"],"award-info":[{"award-number":["Posdoctorado CVU: 620020"]}],"id":[{"id":"https:\/\/ror.org\/059ex5q34","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Secretar\u00eda de Salud Mexico","award":["FPIS2024-HIM-6904"],"award-info":[{"award-number":["FPIS2024-HIM-6904"]}],"id":[{"id":"https:\/\/ror.org\/0082wq496","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009609","name":"Hospital Infantil de M\u00e9xico Federico G\u00f3mez","doi-asserted-by":"publisher","award":["HIM\/2021\/038 SSA 1781"],"award-info":[{"award-number":["HIM\/2021\/038 SSA 1781"]}],"id":[{"id":"10.13039\/501100009609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["PAFRIM-FACMED 2026"],"award-info":[{"award-number":["PAFRIM-FACMED 2026"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04413-6","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:29:34Z","timestamp":1780658974000},"page":"5103-5116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell surface GRP78 and the UPR pathway as novel promising therapeutic targets in cancer: an insight into the treatment of acute leukemia by using GRP78-CART cells"],"prefix":"10.1007","volume":"28","author":[{"given":"Nadia Giovanna","family":"Rom\u00e1n-Anguiano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Andrea","family":"Guti\u00e9rrez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Angeles-Floriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy Lucero","family":"Mart\u00ednez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"Guti\u00e9rrez-Kobeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C","family":"Jimenez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-963X","authenticated-orcid":false,"given":"Ricardo","family":"Valle-Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"1","key":"4413_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0042-6822(74)90143-3","volume":"58","author":"KR Stone","year":"1974","unstructured":"Stone KR, Smith RE, Joklik WK. Changes in membrane polypeptides that occur when chick embryo fibroblasts and NRK cells are transformed with avian sarcoma viruses. Virology. 1974;58(1):86\u2013100. https:\/\/doi.org\/10.1016\/0042-6822(74)90143-3.","journal-title":"Virology"},{"issue":"1","key":"4413_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/0042-6822(75)90023-9","volume":"65","author":"T Isaka","year":"1975","unstructured":"Isaka T, Yoshida M, Owada M, Toyoshima K. Alterations in membrane polypeptides of chick embryo fibroblasts induced by transformation with avian sarcoma viruses. Virology. 1975;65(1):226\u201337. https:\/\/doi.org\/10.1016\/0042-6822(75)90023-9.","journal-title":"Virology"},{"issue":"9","key":"4413_CR3","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1073\/pnas.74.9.3840","volume":"74","author":"RP Shiu","year":"1977","unstructured":"Shiu RP, Pouyssegur J, Pastan I. Glucose depletion accounts for the induction of two transformation-sensitive membrane proteinsin Rous sarcoma virus-transformed chick embryo fibroblasts. Proc Natl Acad Sci U S A. 1977;74(9):3840\u20134. https:\/\/doi.org\/10.1073\/pnas.74.9.3840.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4413_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gene.2017.03.005","volume":"618","author":"J Wang","year":"2017","unstructured":"Wang J, Lee J, Liem D, Ping P. HSPA5 gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum. Gene. 2017;618:14\u201323. https:\/\/doi.org\/10.1016\/j.gene.2017.03.005.","journal-title":"Gene"},{"key":"4413_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1166680","volume":"14","author":"T Li","year":"2023","unstructured":"Li T, Fu J, Cheng J, Elfiky AA, Wei C, Fu J. New progresses on cell surface protein HSPA5\/BiP\/GRP78 in cancers and COVID-19. Front Immunol. 2023;14:1166680. https:\/\/doi.org\/10.3389\/fimmu.2023.1166680.","journal-title":"Front Immunol"},{"issue":"9","key":"4413_CR6","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1089\/ars.2009.2485","volume":"11","author":"M Wang","year":"2009","unstructured":"Wang M, Wey S, Zhang Y, Ye R, Lee AS. Role of the unfolded protein response regulator GRP78\/BiP in development, cancer, and neurological disorders. Antioxid Redox Signal. 2009;11(9):2307\u201316. https:\/\/doi.org\/10.1089\/ars.2009.2485.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"4413_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/156652406775574523","volume":"6","author":"J Li","year":"2006","unstructured":"Li J, Lee AS. Stress induction of GRP78\/BiP and its role in cancer. Curr Mol Med. 2006;6(1):45\u201354. https:\/\/doi.org\/10.2174\/156652406775574523.","journal-title":"Curr Mol Med"},{"issue":"6059","key":"4413_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1126\/science.1209038","volume":"334","author":"P Walter","year":"2011","unstructured":"Walter P, Ron D. The unfolded protein response: from stress pathway to homeostatic regulation. Science (New York, NY). 2011;334(6059):1081\u20136. https:\/\/doi.org\/10.1126\/science.1209038.","journal-title":"Science (New York, NY)"},{"issue":"11","key":"4413_CR9","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1091\/mbc.E17-10-0594","volume":"29","author":"A Sundaram","year":"2018","unstructured":"Sundaram A, Appathurai S, Plumb R, Mariappan M. Dynamic changes in complexes of IRE1\u03b1, PERK, and ATF6\u03b1 during endoplasmic reticulum stress. Mol Biol Cell. 2018;29(11):1376\u201388. https:\/\/doi.org\/10.1091\/mbc.E17-10-0594.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"4413_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05857-w","volume":"12","author":"T Angeles-Floriano","year":"2022","unstructured":"Angeles-Floriano T, Rivera-Torruco G, Garc\u00eda-Maldonado P, Ju\u00e1rez E, Gonzalez Y, Parra-Ortega I, et al. Cell surface expression of GRP78 and CXCR4 is associated with childhood high-risk acute lymphoblastic leukemia at diagnostics. Sci Rep. 2022;12(1):2322. https:\/\/doi.org\/10.1038\/s41598-022-05857-w.","journal-title":"Sci Rep"},{"issue":"19","key":"4413_CR11","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1158\/0008-5472.CAN-06-4686","volume":"67","author":"CG Jakobsen","year":"2007","unstructured":"Jakobsen CG, Rasmussen N, Laenkholm AV, Ditzel HJ. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78. Cancer Res. 2007;67(19):9507\u201317. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4686.","journal-title":"Cancer Res"},{"issue":"9","key":"4413_CR12","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1074\/jbc.M210455200","volume":"278","author":"BK Shin","year":"2003","unstructured":"Shin BK, Wang H, Yim AM, Le Naour F, Brichory F, Jang JH, et al. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem. 2003;278(9):7607\u201316. https:\/\/doi.org\/10.1074\/jbc.M210455200.","journal-title":"J Biol Chem"},{"issue":"1","key":"4413_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.lungcan.2004.12.011","volume":"49","author":"H Uramoto","year":"2005","unstructured":"Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, Yoshimastu T, et al. Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance. Lung cancer (Amst, Neth). 2005;49(1):55\u201362. https:\/\/doi.org\/10.1016\/j.lungcan.2004.12.011.","journal-title":"Lung cancer (Amst, Neth)"},{"issue":"1","key":"4413_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1023\/a:1006332011207","volume":"59","author":"PM Fernandez","year":"2000","unstructured":"Fernandez PM, Tabbara SO, Jacobs LK, Manning FC, Tsangaris TN, Schwartz AM, et al. Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions. Breast Cancer Res Treat. 2000;59(1):15\u201326. https:\/\/doi.org\/10.1023\/a:1006332011207.","journal-title":"Breast Cancer Res Treat"},{"issue":"1-2","key":"4413_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.cca.2005.07.016","volume":"364","author":"X Xing","year":"2006","unstructured":"Xing X, Lai M, Wang Y, Xu E, Huang Q. Overexpression of glucose-regulated protein 78 in colon cancer. Clin Chim Acta. 2006;364(1\u20132):308\u201315. https:\/\/doi.org\/10.1016\/j.cca.2005.07.016.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"4413_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.ymeth.2005.03.001","volume":"35","author":"SH Back","year":"2005","unstructured":"Back SH, Schr\u00f6der M, Lee K, Zhang K, Kaufman RJ. ER stress signaling by regulated splicing: IRE1\/HAC1\/XBP1. Methods. 2005;35(4):395\u2013416. https:\/\/doi.org\/10.1016\/j.ymeth.2005.03.001.","journal-title":"Methods"},{"issue":"7","key":"4413_CR17","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrm2199","volume":"8","author":"D Ron","year":"2007","unstructured":"Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8(7):519\u201329. https:\/\/doi.org\/10.1038\/nrm2199.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"4413_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/febs.14608","volume":"286","author":"A Almanza","year":"2019","unstructured":"Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, et al. Endoplasmic reticulum stress signalling: from basic mechanisms to clinical applications. FEBS J. 2019;286(2):241\u201378. https:\/\/doi.org\/10.1111\/febs.14608.","journal-title":"FEBS J"},{"issue":"17","key":"4413_CR19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153519","volume":"132","author":"MJ Grey","year":"2022","unstructured":"Grey MJ, De Luca H, Ward DV, Kreulen IA, Bugda Gwilt K, Foley SE, et al. The epithelial-specific ER stress sensor ERN2\/IRE1\u03b2 enables host-microbiota crosstalk to affect colon goblet cell development. J Clin Invest. 2022;132(17):e153519. https:\/\/doi.org\/10.1172\/JCI153519.","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"4413_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mrfmmm.2004.06.056","volume":"569","author":"M Schr\u00f6der","year":"2005","unstructured":"Schr\u00f6der M, Kaufman RJ. ER stress and the unfolded protein response. Mutat Res. 2005;569(1\u20132):29\u201363. https:\/\/doi.org\/10.1016\/j.mrfmmm.2004.06.056.","journal-title":"Mutat Res"},{"issue":"2","key":"4413_CR21","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz C, Papa FR. The unfolded protein response and cell fate control. Mol Cell. 2018;69(2):169\u201381. https:\/\/doi.org\/10.1016\/j.molcel.2017.06.017.","journal-title":"Mol Cell"},{"issue":"27","key":"4413_CR22","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1038\/onc.2010.153","volume":"29","author":"E Bobrovnikova-Marjon","year":"2010","unstructured":"Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C, et al. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene. 2010;29(27):3881\u201395. https:\/\/doi.org\/10.1038\/onc.2010.153.","journal-title":"Oncogene"},{"key":"4413_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2024.106598","volume":"172","author":"P Kettel","year":"2024","unstructured":"Kettel P, Karag\u00f6z GE. Endoplasmic reticulum: monitoring and maintaining protein and membrane homeostasis in the endoplasmic reticulum by the unfolded protein response. Int J Biochem Cell Biol. 2024;172:106598. https:\/\/doi.org\/10.1016\/j.biocel.2024.106598.","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"4413_CR24","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41594-019-0324-9","volume":"26","author":"MC Kopp","year":"2019","unstructured":"Kopp MC, Larburu N, Durairaj V, Adams CJ, Ali MMU. UPR proteins IRE1 and PERK switch BiP from chaperone to ER stress sensor. Nat Struct Mol Biol. 2019;26(11):1053\u201362. https:\/\/doi.org\/10.1038\/s41594-019-0324-9.","journal-title":"Nat Struct Mol Biol"},{"issue":"12","key":"4413_CR25","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1016\/j.bbamcr.2013.06.028","volume":"1833","author":"R Sano","year":"2013","unstructured":"Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochim Biophys Acta. 2013;1833(12):3460\u201370. https:\/\/doi.org\/10.1016\/j.bbamcr.2013.06.028.","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"4413_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417321","volume":"24","author":"D Hicks","year":"2023","unstructured":"Hicks D, Giresh K, Wrischnik LA, Weiser DC. The PPP1R15 family of eIF2-alpha phosphatase targeting subunits (GADD34 and CReP). Int J Mol Sci. 2023;24(24):17321. https:\/\/doi.org\/10.3390\/ijms242417321.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4413_CR27","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.18632\/oncotarget.6361","volume":"7","author":"F Buontempo","year":"2016","unstructured":"Buontempo F, Orsini E, Lonetti A, Cappellini A, Chiarini F, Evangelisti C, et al. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP\/Grp78 and turning on the pro-apoptotic NF-\u03baB. Oncotarget. 2016;7(2):1323\u201340. https:\/\/doi.org\/10.18632\/oncotarget.6361.","journal-title":"Oncotarget"},{"issue":"1","key":"4413_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pcl.2014.09.004","volume":"62","author":"D Bhojwani","year":"2015","unstructured":"Bhojwani D, Yang JJ, Pui CH. Biology of childhood acute lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):47\u201360. https:\/\/doi.org\/10.1016\/j.pcl.2014.09.004.","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"4413_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cll.2021.04.003","volume":"41","author":"DC Luca","year":"2021","unstructured":"Luca DC. Update on lymphoblastic leukemia\/lymphoma. Clin Lab Med. 2021;41(3):405\u201316. https:\/\/doi.org\/10.1016\/j.cll.2021.04.003.","journal-title":"Clin Lab Med"},{"issue":"1","key":"4413_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1182\/asheducation-2016.1.580","volume":"2016","author":"EA Raetz","year":"2016","unstructured":"Raetz EA, Teachey DT. T-cell acute lymphoblastic leukemia. Hematology. 2016;2016(1):580\u20138. https:\/\/doi.org\/10.1182\/asheducation-2016.1.580.","journal-title":"Hematology"},{"issue":"11","key":"4413_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ph16111614","volume":"16","author":"S Tseng","year":"2023","unstructured":"Tseng S, Lee ME, Lin PC. A review of childhood acute myeloid leukemia: diagnosis and novel treatment. Pharmaceuticals (Basel, Switz). 2023;16(11):1614. https:\/\/doi.org\/10.3390\/ph16111614.","journal-title":"Pharmaceuticals (Basel, Switz)"},{"issue":"3","key":"4413_CR32","first-page":"38","volume":"103","author":"A Pelcovits","year":"2020","unstructured":"Pelcovits A, Niroula R. Acute myeloid leukemia: a review. R Isl Med J (2013). 2020;103(3):38\u201340.","journal-title":"R Isl Med J (2013)"},{"issue":"8","key":"4413_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00262-011-1195-z","volume":"61","author":"L Huergo-Zapico","year":"2012","unstructured":"Huergo-Zapico L, Gonzalez-Rodriguez AP, Contesti J, Gonzalez E, L\u00f3pez-Soto A, Fernandez-Guizan A, et al. Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding. Cancer Immunol Immunother. 2012;61(8):1201\u201310. https:\/\/doi.org\/10.1007\/s00262-011-1195-z.","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"4413_CR34","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1365-2141.2011.08671.x","volume":"153","author":"FM Uckun","year":"2011","unstructured":"Uckun FM, Qazi S, Ozer Z, Garner AL, Pitt J, Ma H, et al. Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network. Br J Haematol. 2011;153(6):741\u201352. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08671.x.","journal-title":"Br J Haematol"},{"issue":"21","key":"4413_CR35","doi-asserted-by":"publisher","first-page":"E2219","DOI":"10.1073\/pnas.1400958111","volume":"111","author":"B Kharabi Masouleh","year":"2014","unstructured":"Kharabi Masouleh B, Geng H, Hurtz C, Chan LN, Logan AC, Chang MS, et al. Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2014;111(21):E2219\u201328. https:\/\/doi.org\/10.1073\/pnas.1400958111.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4413_CR36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/tpj.2017.46","volume":"18","author":"DI Staquicini","year":"2018","unstructured":"Staquicini DI, D\u2019Angelo S, Ferrara F, Karjalainen K, Sharma G, Smith TL, et al. Therapeutic targeting of membrane-associated GRP78 in leukemia and lymphoma: preclinical efficacy in vitro and formal toxicity study of BMTP-78 in rodents and primates. Pharmacogenomics J. 2018;18(3):436\u201343. https:\/\/doi.org\/10.1038\/tpj.2017.46.","journal-title":"Pharmacogenomics J"},{"key":"4413_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.648752","volume":"8","author":"P Wang","year":"2021","unstructured":"Wang P, Han L, Yu M, Cao Z, Li X, Shao Y, et al. The prognostic value of PERK in cancer and its relationship with immune cell infiltration. Front Mol Biosci. 2021;8:648752. https:\/\/doi.org\/10.3389\/fmolb.2021.648752.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"4413_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110197","volume":"38","author":"A Grenier","year":"2022","unstructured":"Grenier A, Poulain L, Mondesir J, Jacquel A, Bosc C, Stuani L, et al. AMPK\u2013PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia. Cell Rep. 2022;38(1):110197. https:\/\/doi.org\/10.1016\/j.celrep.2021.110197.","journal-title":"Cell Rep"},{"issue":"6","key":"4413_CR39","doi-asserted-by":"publisher","first-page":"7886","DOI":"10.3892\/mmr.2018.8840","volume":"17","author":"LJ Li","year":"2018","unstructured":"Li LJ, Chai Y, Guo XJ, Chu SL, Zhang LS. Effects of endoplasmic reticulum stress on autophagy and apoptosis of human leukemia cells via inhibition of the PI3K\/AKT\/mTOR signaling pathway. Mol Med Rep. 2018;17(6):7886\u201392. https:\/\/doi.org\/10.3892\/mmr.2018.8840.","journal-title":"Mol Med Rep"},{"issue":"16","key":"4413_CR40","doi-asserted-by":"publisher","first-page":"26613","DOI":"10.18632\/oncotarget.15772","volume":"8","author":"D Tsitsipatis","year":"2017","unstructured":"Tsitsipatis D, Jayavelu AK, M\u00fcller JP, Bauer R, Schmidt-Arras D, Mahboobi S, et al. Synergistic killing of FLT3ITD-positive AML cells by combined inhibition of tyrosine-kinase activity and N-glycosylation. Oncotarget. 2017;8(16):26613\u201324. https:\/\/doi.org\/10.18632\/oncotarget.15772.","journal-title":"Oncotarget"},{"issue":"1","key":"4413_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13046-020-01565-3","volume":"39","author":"JE Jang","year":"2020","unstructured":"Jang JE, Eom JI, Jeung HK, Chung H, Kim YR, Kim JS, et al. PERK\/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells. J Exp Clin Cancer Res. 2020;39(1):66. https:\/\/doi.org\/10.1186\/s13046-020-01565-3.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"4413_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05033-5","volume":"7","author":"C Wang","year":"2017","unstructured":"Wang C, Xu CX, Alippe Y, Qu C, Xiao J, Schipani E, et al. Chronic inflammation triggered by the NLRP3 inflammasome in myeloid cells promotes growth plate dysplasia by mesenchymal cells. Sci Rep. 2017;7(1):4880. https:\/\/doi.org\/10.1038\/s41598-017-05033-5.","journal-title":"Sci Rep"},{"issue":"1","key":"4413_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01777-6","volume":"22","author":"M Luciano","year":"2024","unstructured":"Luciano M, Sieberer H, Krenn PW, Dang HH, Vetter J, Neuper T, et al. Targeting NLRP3 inhibits AML progression by inducing PERK\/eIF2-mediated apoptosis. Cell Commun Signal. 2024;22(1):424. https:\/\/doi.org\/10.1186\/s12964-024-01777-6.","journal-title":"Cell Commun Signal"},{"issue":"21","key":"4413_CR44","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.4161\/cc.22387","volume":"11","author":"M Kusio-Kobialka","year":"2012","unstructured":"Kusio-Kobialka M, Podszywalow-Bartnicka P, Peidis P, Glodkowska-Mrowka E, Wolanin K, Leszak G, et al. The PERK-eIF2\u03b1 phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells. Cell Cycle. 2012;11(21):4069\u201378. https:\/\/doi.org\/10.4161\/cc.22387.","journal-title":"Cell Cycle"},{"issue":"6","key":"4413_CR45","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.7150\/thno.67710","volume":"12","author":"C Liu","year":"2022","unstructured":"Liu C, Chen Q, Shang Y, Chen L, Myers J, Awadallah A, et al. Endothelial PERK\u2013ATF4\u2013JAG1 axis activated by T-ALL remodels bone marrow vascular niche. Theranostics. 2022;12(6):2894\u2013907. https:\/\/doi.org\/10.7150\/thno.67710.","journal-title":"Theranostics"},{"issue":"2","key":"4413_CR46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.canlet.2015.02.024","volume":"360","author":"JH Lee","year":"2015","unstructured":"Lee JH, Kim C, Kim SH, Sethi G, Ahn KS. Farnesol inhibits tumor growth and enhances the anticancer effects of bortezomib in multiple myeloma xenograft mouse model through the modulation of STAT3 signaling pathway. Cancer Lett. 2015;360(2):280\u201393. https:\/\/doi.org\/10.1016\/j.canlet.2015.02.024.","journal-title":"Cancer Lett"},{"issue":"3","key":"4413_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bcp.2015.08.086","volume":"97","author":"JH Joo","year":"2015","unstructured":"Joo JH, Ueda E, Bortner CD, Yang XP, Liao G, Jetten AM. Farnesol activates the intrinsic pathway of apoptosis and the ATF4\u2013ATF3\u2013CHOP cascade of ER stress in human T lymphoblastic leukemia Molt4 cells. Biochem Pharmacol. 2015;97(3):256\u201368. https:\/\/doi.org\/10.1016\/j.bcp.2015.08.086.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"4413_CR48","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1158\/1541-7786.MCR-19-0002","volume":"17","author":"J Gui","year":"2019","unstructured":"Gui J, Katlinski KV, Koumenis C, Diehl JA, Fuchs SY. The PKR-like endoplasmic reticulum kinase promotes the dissemination of Myc-induced leukemic cells. Mol Cancer Res. 2019;17(7):1450\u20138. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0002.","journal-title":"Mol Cancer Res"},{"issue":"11","key":"4413_CR49","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1038\/s41375-018-0141-x","volume":"32","author":"LN Huiting","year":"2018","unstructured":"Huiting LN, Samaha Y, Zhang GL, Roderick JE, Li B, Anderson NM, et al. UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response. Leukemia. 2018;32(11):2339\u201351. https:\/\/doi.org\/10.1038\/s41375-018-0141-x.","journal-title":"Leukemia"},{"issue":"1","key":"4413_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41375-021-01378-z","volume":"36","author":"Q Liu","year":"2022","unstructured":"Liu Q, Chan AKN, Chang WH, Yang L, Pokharel SP, Miyashita K, et al. 3-Ketodihydrosphingosine reductase maintains ER homeostasis and unfolded protein response in leukemia. Leukemia. 2022;36(1):100\u201310. https:\/\/doi.org\/10.1038\/s41375-021-01378-z.","journal-title":"Leukemia"},{"issue":"8","key":"4413_CR51","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/s41375-024-02321-8","volume":"38","author":"C Philippe","year":"2024","unstructured":"Philippe C, Jaud M, F\u00e9ral K, Gay A, Van Den Berghe L, Farce M, et al. Pivotal role of the endoplasmic reticulum stress-related XBP1s\/miR-22\/SIRT1 axis in acute myeloid leukemia apoptosis and response to chemotherapy. Leukemia. 2024;38(8):1764\u201376. https:\/\/doi.org\/10.1038\/s41375-024-02321-8.","journal-title":"Leukemia"},{"issue":"4","key":"4413_CR52","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41419-021-03555-5","volume":"12","author":"C Li","year":"2021","unstructured":"Li C, Huang Y, Fan Q, Quan H, Dong Y, Nie M, et al. p97\/VCP is highly expressed in the stem-like cells of breast cancer and controls cancer stemness partly through the unfolded protein response. Cell Death Dis. 2021;12(4):286. https:\/\/doi.org\/10.1038\/s41419-021-03555-5.","journal-title":"Cell Death Dis"},{"issue":"11","key":"4413_CR53","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1111\/cas.14184","volume":"110","author":"H Luo","year":"2019","unstructured":"Luo H, Song H, Mao R, Gao Q, Feng Z, Wang N, et al. Targeting valosin-containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma. Cancer Sci. 2019;110(11):3464\u201375. https:\/\/doi.org\/10.1111\/cas.14184.","journal-title":"Cancer Sci"},{"issue":"13","key":"4413_CR54","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1200\/JCO.2003.12.102","volume":"21","author":"S Yamamoto","year":"2003","unstructured":"Yamamoto S, Tomita Y, Hoshida Y, Takiguchi S, Fujiwara Y, Yasuda T, et al. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J Clin Oncol. 2003;21(13):2537\u201344. https:\/\/doi.org\/10.1200\/JCO.2003.12.102.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4413_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/prca.202200109","volume":"17","author":"FW Hoff","year":"2023","unstructured":"Hoff FW, Qiu Y, Brown BD, Gerbing RB, Leonti AR, Ries RE, et al. Valosin-containing protein (VCP\/p97) is prognostically unfavorable in pediatric AML, and negatively correlates with unfolded protein response proteins IRE1 and GRP78: a report from the Children\u2019s Oncology Group. Proteom Clin Appl. 2023;17(6):e2200109. https:\/\/doi.org\/10.1002\/prca.202200109.","journal-title":"Proteom Clin Appl"},{"issue":"612","key":"4413_CR56","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh3462","volume":"13","author":"J Zhou","year":"2021","unstructured":"Zhou J, Wang S, Nie D, Lai P, Li Y, Li Y, et al. Super-enhancer landscape reveals leukemia stem cell reliance on X-box binding protein 1 as a therapeutic vulnerability. Sci Transl Med. 2021;13(612):eabh3462. https:\/\/doi.org\/10.1126\/scitranslmed.abh3462.","journal-title":"Sci Transl Med"},{"issue":"14","key":"4413_CR57","doi-asserted-by":"publisher","first-page":"18736","DOI":"10.18632\/oncotarget.7702","volume":"7","author":"H Sun","year":"2016","unstructured":"Sun H, Lin DC, Guo X, Kharabi Masouleh B, Gery S, Cao Q, et al. Inhibition of IRE1\u03b1-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia. Oncotarget. 2016;7(14):18736\u201349. https:\/\/doi.org\/10.18632\/oncotarget.7702.","journal-title":"Oncotarget"},{"key":"4413_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.598107","volume":"10","author":"J Zi","year":"2020","unstructured":"Zi J, Han Q, Gu S, McGrath M, Kane S, Song C, et al. Targeting NAT10 induces apoptosis associated with enhancing endoplasmic reticulum stress in acute myeloid leukemia cells. Front Oncol. 2020;10:598107. https:\/\/doi.org\/10.3389\/fonc.2020.598107.","journal-title":"Front Oncol"},{"issue":"2","key":"4413_CR59","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/ijms21020440","volume":"21","author":"S Gurunathan","year":"2020","unstructured":"Gurunathan S, Jeyaraj M, La H, Yoo H, Choi Y, Do JT, et al. Anisotropic platinum nanoparticle-induced cytotoxicity, apoptosis, inflammatory response, and transcriptomic and molecular pathways in human acute monocytic leukemia cells. Int J Mol Sci. 2020;21(2):440. https:\/\/doi.org\/10.3390\/ijms21020440.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4413_CR60","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1158\/1535-7163.MCT-13-0714","volume":"13","author":"TK Nguyen","year":"2014","unstructured":"Nguyen TK, Grant S. Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanism. Mol Cancer Ther. 2014;13(3):662\u201374. https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0714.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"4413_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56520-7","volume":"16","author":"X Sun","year":"2025","unstructured":"Sun X, Li Y, Du J, Liu F, Wu C, Xiao W, et al. Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78\u2013ATF6\u2013CHOP axis. Nat Commun. 2025;16(1):1358. https:\/\/doi.org\/10.1038\/s41467-025-56520-7.","journal-title":"Nat Commun"},{"issue":"40","key":"4413_CR62","doi-asserted-by":"publisher","first-page":"35227","DOI":"10.1074\/jbc.M111.233502","volume":"286","author":"N Morishima","year":"2011","unstructured":"Morishima N, Nakanishi K, Nakano A. Activating transcription factor-6 (ATF6) mediates apoptosis with reduction of myeloid cell leukemia sequence 1 (Mcl-1) protein via induction of WW domain binding protein 1. J Biol Chem. 2011;286(40):35227\u201335. https:\/\/doi.org\/10.1074\/jbc.M111.233502.","journal-title":"J Biol Chem"},{"issue":"6B","key":"4413_CR63","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1111\/j.1582-4934.2009.00870.x","volume":"14","author":"JA Schardt","year":"2010","unstructured":"Schardt JA, Eyholzer M, Timchenko NA, Mueller BU, Pabst T. Unfolded protein response suppresses CEBPA by induction of calreticulin in acute myeloid leukaemia. J Cell Mol Med. 2010;14(6B):1509\u201319. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00870.x.","journal-title":"J Cell Mol Med"},{"issue":"42","key":"4413_CR64","doi-asserted-by":"publisher","first-page":"22030","DOI":"10.1074\/jbc.M116.725796","volume":"291","author":"P Gade","year":"2016","unstructured":"Gade P, Kimball AS, DiNardo AC, Gangwal P, Ross DD, Boswell HS, et al. Death-associated protein kinase-1 expression and autophagy in chronic lymphocytic leukemia are dependent on activating transcription factor-6 and CCAAT\/enhancer-binding protein-\u03b2. J Biol Chem. 2016;291(42):22030\u201342. https:\/\/doi.org\/10.1074\/jbc.M116.725796.","journal-title":"J Biol Chem"},{"issue":"1","key":"4413_CR65","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","volume":"41","author":"K Pan","year":"2022","unstructured":"Pan K, Farrukh H, Chittepu VCSR, Xu H, Pan CX, Zhu Z. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy. J Exp Clin Cancer Res. 2022;41(1):119. https:\/\/doi.org\/10.1186\/s13046-022-02327-z.","journal-title":"J Exp Clin Cancer Res"},{"key":"4413_CR66","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-1-0716-0759-6_14","volume":"2174","author":"A Cort\u00e9s-Hern\u00e1ndez","year":"2021","unstructured":"Cort\u00e9s-Hern\u00e1ndez A, Alvarez-Salazar EK, Soldevila G. Chimeric antigen receptor (CAR) T-cell therapy for cancer: challenges and opportunities\u2014an overview. Methods Mol Biol (Clifton, NJ). 2021;2174:219\u201344. https:\/\/doi.org\/10.1007\/978-1-0716-0759-6_14.","journal-title":"Methods Mol Biol (Clifton, N.J.)"},{"issue":"5","key":"4413_CR67","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s11427-018-9451-0","volume":"62","author":"C Lin","year":"2019","unstructured":"Lin C, Zhang J. Chimeric antigen receptor engineered innate immune cells in cancer immunotherapy. Sci China Life Sci. 2019;62(5):633\u20139. https:\/\/doi.org\/10.1007\/s11427-018-9451-0.","journal-title":"Sci China Life Sci"},{"key":"4413_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.928140","volume":"10","author":"W Yu","year":"2022","unstructured":"Yu W, Zhang H, Yuan Y, Tang J, Chen X, Liu T, et al. Chimeric antigen receptor T cells targeting cell surface GRP78 to eradicate acute myeloid leukemia. Front Cell Dev Biol. 2022;10:928140. https:\/\/doi.org\/10.3389\/fcell.2022.928140.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4413_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28243-6","volume":"13","author":"N Hebbar","year":"2022","unstructured":"Hebbar N, Epperly R, Vaidya A, Thanekar U, Moore SE, Umeda M, et al. CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells. Nat Commun. 2022;13(1):587. https:\/\/doi.org\/10.1038\/s41467-022-28243-6.","journal-title":"Nat Commun"},{"issue":"1","key":"4413_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010564","volume":"25","author":"S Wang","year":"2024","unstructured":"Wang S, Wei W, Yuan Y, Guo J, Liang D, Zhao X. Cell-surface GRP78-targeted chimeric antigen receptor T cells eliminate lung cancer tumor xenografts. Int J Mol Sci. 2024;25(1):564. https:\/\/doi.org\/10.3390\/ijms25010564.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4413_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101297","volume":"4","author":"J Ibanez","year":"2023","unstructured":"Ibanez J, Hebbar N, Thanekar U, Yi Z, Houke H, Ward M, et al. GRP78-CAR T-cell effector function against solid and brain tumors is controlled by GRP78 expression on T cells. Cell Rep Med. 2023;4(11):101297. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101297.","journal-title":"Cell Rep Med"},{"issue":"1","key":"4413_CR72","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12967-023-04330-0","volume":"21","author":"S Wang","year":"2023","unstructured":"Wang S, Wei W, Yuan Y, Sun B, Yang D, Liu N, et al. Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells. J Transl Med. 2023;21(1):493. https:\/\/doi.org\/10.1186\/s12967-023-04330-0.","journal-title":"J Transl Med"},{"key":"4413_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101803","volume":"39","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Fan J, Liang D, Wang S, Luo X, Zhu Y, et al. Cell surface GRP78-directed CAR-T cells are effective at treating human pancreatic cancer in preclinical models. Transl Oncol. 2024;39:101803. https:\/\/doi.org\/10.1016\/j.tranon.2023.101803.","journal-title":"Transl Oncol"},{"issue":"4","key":"4413_CR74","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10439-024-03673-z","volume":"53","author":"MB Alvarez-Elizondo","year":"2025","unstructured":"Alvarez-Elizondo MB, Raiter A, Yerushalmi R, Weihs D. Chemotherapy-induced cell-surface GRP78 expression as a prognostic marker for invasiveness of metastatic triple-negative breast cancer. Ann Biomed Eng. 2025;53(4):881\u201390. https:\/\/doi.org\/10.1007\/s10439-024-03673-z.","journal-title":"Ann Biomed Eng"},{"issue":"32","key":"4413_CR75","doi-asserted-by":"publisher","first-page":"13322","DOI":"10.1039\/d3nr00800b","volume":"15","author":"J Shin","year":"2023","unstructured":"Shin J, Kim B, Lager TW, Mejia F, Guldner I, Conner C, et al. A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78. Nanoscale. 2023;15(32):13322\u201334. https:\/\/doi.org\/10.1039\/d3nr00800b.","journal-title":"Nanoscale"},{"issue":"1","key":"4413_CR76","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41419-022-04522-4","volume":"13","author":"X Fu","year":"2022","unstructured":"Fu X, Liu J, Liu D, Zhou Y, Guo Y, Wang Z, et al. Glucose-regulated protein 78 modulates cell growth, epithelial\u2013mesenchymal transition, and oxidative stress in the hyperplastic prostate. Cell Death Dis. 2022;13(1):78. https:\/\/doi.org\/10.1038\/s41419-022-04522-4.","journal-title":"Cell Death Dis"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04413-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04413-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04413-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:01:46Z","timestamp":1792803706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04413-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":76,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["4413"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04413-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Since this is a review paper, no new data were created or analyzed in this study. Therefore, conflict of interest, ethical approval (research involving human participants and\/or animals), and informed consent statements are not required.","order":1,"name":"Ethics","label":"conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}